Hilary Evans-Newton
Hilary Evans-Newton is the chief executive of Alzheimer's Research UK and has been vocal about the implications of the NHS's decision to reject new Alzheimer's drugs, calling it painful and highlighting that patients will miss out on vital innovations due to systemic failures rather than scientific shortcomings.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Kingdom:
Hilary Evans-Newton, the chief executive at Alzheimer's Research UK, said the result was 'painful'.
5